Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001753926-25-001077
Filing Date
2025-07-03
Accepted
2025-07-03 21:04:18
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 10442
  Complete submission text file 0001753926-25-001077.txt   12054
Mailing Address 205 NEWBURY ST SUITE 204 FRAMINGHAM MA 01701
Business Address
Francis Knuettel II (Reporting) CIK: 0001433316 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41964 | Film No.: 251106834

Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Pelthos Therapeutics Inc. (Issuer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)